Development of aGD2–SIRPα Fusion Antibodies Targeting Neuroblastoma and the Innate Immune Checkpoint Receptor CD47
Year: 2025
Type: article
Source: Molecular Cancer Therapeutics
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
Awards: G3492314754, G8217508484
OpenAlex ID: W4414917812
